Gö 6983: A fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury

Cardiovascular Drug Reviews

Volumn 23, Issue 3, 2005, Pages 255-272

  Young, Lindon H ^a   Balin, Brian J ^a   Weis, Margaret T ^b  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

G 6983; Ischemia reperfusion injury; Myocardial protection; Protein kinase C; Protein kinase C inhibitors

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 2 [8 (AMINOMETHYL) 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 (8 AMINOMETHYL 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL) 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; 3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; CALPHOSTIN C; CHELERYTHRINE; NITRIC OXIDE; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; STAUROSPORINE; SUPEROXIDE; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; DRUG EFFICACY; DRUG MECHANISM; DRUG SOLUBILITY; ENDOTHELIUM; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE MIGRATION; NONHUMAN; ORGAN TRANSPLANTATION; POLLEN ALLERGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASOCONSTRICTION; VASODILATATION;

EID: 27644554420     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2005.tb00170.x     Document Type: Review

References (82)

1. Aronowski J, Grotta JC, Strong R, Waxham MN. Interplay between the gamma isoforms of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. J Cereb Blood Flow Metab 2000;20:343-349.
2. Becker KJ. Targeting the central nervous system inflammatory response in ischemic stroke. Curr Opin Neurol 2001;14:349-353.
3. Bednar MSB, Pinto A, Mullane KM. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 1985;57:131-141.
4. Bright R, Raval AP, Dembner JM, et al. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 2004;24:6880-6888.
5. Buerke M, Weyrich AS, Lefer AM. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. Am J Physiol 1994;266:H128-H136.
6. Cavanagh SP, Gough MJ, Homer-Vanniasinkam S. The role of the neutrophil in ischaemia-reperfusion injury: Potential therapeutic interventions. Cardiovasc Res 1998;6:112-118.
7. Chen X, Catravàs JD. Release of a leukocyte activation inhibitor by staurosporine-treated pulmonary artery endothelial cells. Am J Physiol 1998;275:184-192.
8. Chou W-H, Choi D-S, Zhang H, et al. Neutrophil protein kinase C δ as a mediator of stroke-reperfusion injury. J Clin Invest 2004;114:49-56.
9. Clerk A. Death by a protein kinase C inhibitor: A stressful event. J Mol Cell Cardiol 2001;33:1773-1776.
10. Dang P, Fontayne A, Hakim J, Benna J, Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NAPDH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol 2001;166:1206-1213.
11. Das DK. Protein kinase C isozymes signaling in the heart. J Mol Cell Cardiol 2003;35:887-889.
12. Dekker LV, Leitges M, Altschuler G, et al. A Protein kinase C-β contributes to NADPH oxidase activation in neutrophils. Biochem J 2000;347:285-289.
13. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002;22:1399-1419.
14. β. Bioorg Med Chem Lett 2003;13:1857-1859.
15. ζ regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 2002;90:1012-1019.
16. Goekjian PG, Jirousek M. Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development. Cur Med Chem 1999;6:877-903.
17. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ. Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase C isoenzymes. FEBS Lett 1996;392:77-80.
18. Gschwendt M, Kittstein W, Johannes FJ. Differential effects of suramin on protein kinase C isoenzymes. A novel tool for discriminating protein kinase C activities. FEBS Lett 1998;421:165-168.
19. Hirata K, Kuroda R, Sakoda T, et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 1995;25:180-185.
20. Hug H, Sarre T. Protein kinase C isoenzymes: Divergence in signal transduction. Biochem J 1993;291:329-343.
21. Inagaki K, Hahn H S., Dorn II G W. Mochly-Rosen, D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and delta-protein kinase C activator. Circulation 2003;108:869.
22. Inagaki K, Leon C, Ikeno F, et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003;108:2304-2307.
23. β inhibitor. Science 1996;272:728-731.
24. Jean WC, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery 1998;43;1382-1396.
25. Jirousek MR, Gillig JR, Gonzalez CM, et al. (S)-13-[(Dimethylamino) methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k] pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: Isozyme selective inhibitors of protein kinase C β. J Med Chem 1996;39(14):2664-2671.
26. Johnson JA, Barman, SA. Protein kinase C modulation of cyclic GMP in rat neonatal pulmonary vascular smooth muscle. Lung 2004;182:79-89.
27. Kawamura S, Yoshida K-I, Miura T, Mizukami Y, Matsuzaki M. Ischmic preconditioning translocates PKC-δ and -ε, which mediate functional protection in isolated rat heart. Am J Physiol 1998;275:H2266-H2271.
28. Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier J. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol 2001;286:H1339-H1346.
29. Kloner RA, Ellis SG, Lange R. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure, and microvascular damage. Circulation 1985;58:1-8.
30. Koponen S, Kurkinen K, Akerman KE, Mochly-Rosen D, Chan PH, Koistinaho J. Prevention of NMDA-induced death of cortical neurons by inhibition of protein kinase C zeta. J Neurochem 2003;86:442-450.
31. Korchak HM, Kilpatrick LE. Roles for βII-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells. J Biol Chem 2001;276:8910-8917.
32. 2- generation but not degranulation or adherence in differentiated HL60 cells. J Biol Chem 1998;273:27292-27299.
33. Krupinski J, Slevin, MA, Kumar P, Gaffney J, Kaluza J. Protein kinase C expression and activity in the human brain after ischaemic stroke. Acta Neurobiol Exp (Wars.) 1998;58:13-21.
34. Lasley R, Noble M, Mentzer R Jr. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J Mol Cell Cardiol 1997;29:3345-3356.
35. Laudanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC. Evidence of zeta-PKC involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 1998;273:30306.
36. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc Res 1996;32:743-751.
37. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D. Roles of PLC-β2 and -β3 and P13Kγ in chemoattractant-mediated signal transduction. Science 2000;287:1046-1053.
38. Liu H, McPherson BC, Yao Z. Preconditioning attenuates apoptosis and necrosis: Role of protein kinase Cε and -δ isoforms. Am J Physiol Heart Circ Physiol 2001;281:H404-H410.
39. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 1986;26:201-224.
40. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 1989;21:1241-1251.
41. Lundmark JL, Ramasamy R, Vulliet PR, Schaefer S. Chelerythrine increases Na-K-Atpase activity and limits ischemic injury in isolted perfused rat hearts. Am J Physiol (Heart Circ Physiol) 1999;277:H999-H1006.
42. Ma XL, Tsao PS, Viehman GE, Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfusion cat coronary artery. Circ Res 1991;69:95-106.
43. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-412.
44. Ma̧czewski M, Beresewicz A. The role of endothelin, protein kinase C and free radical in the mechanism of the post-ischemic endothelial dysfunction in guinea pig hearts. J Mol Cell Cardiol 2000;332:297-310.
45. Martiny-Baron G, Kazanietz M, Mischak H, et al. Selective inhibition of Protein Kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 1993;268:9194-9197.
46. Matsumoto S, Shamloo M, Matsumoto E, Isshiki A, Wieloch T. Protein kinase C-gamma and calcium/calmodulin-dependent protein kinase II-alpha are persistently translocated to cell membranes of the rat brain during and after middle cerebral artery occlusion. J Cereb Blood Flow Metab 2004;24:54-61.
47. Meyer JW, Holland JA, Ziegler LM, Chang M-M, Beebe G, Schmitt ME. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: A potential atherogenic source of reactive oxygen species. Endothelium 1999;7:11-22.
48. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 1984;228:510-522.
49. Murriel CL, Mochly-Rosen D. Opposing roles of delta and epsilon PKC in cardiac ischemia and reperfusion: Targeting the apoptotic machinery. Arch Biochem Biophys 2003;420:246-254.
50. Numaguchi K, Shimokawa H, Nakaike R, Egashira K, Takeshita A. PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats. Am J Physiol 1996;270:H1634-H1639.
51. Ohlstein EH, Nicholas AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1989;65:917-924.
52. Omiyi D, Brue, RJ, Taormina, P, Harvey M, Atkinson N, Young LH. Protein kinase C βII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury. J Pharmacol Exp Ther 2005;314:542-551.
53. Ozaki, H., Yasuda, K., Kim, YS, et al. Possible Role of the protein kinase C. CPI-17 pathway in the augmented contraction of human myometrium after gestation. Br J Pharm 2003;140:1303-1313.
54. Pabla R, Buda AJ, Flynn DM, et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 1996;78:65-72.
55. Park JW, Babior BM. Activation of leukocyte NADPH oxidase subunit p47phox by protein kinase C. A phosphorylation-dependent change in the conformation of the C-terminal end of p47 phox. Biochemistry 1997;36:7474-7480.
56. Parker PJ, Dekker LV, Eds. Protein kinase C. Austin: R. G. Landes Co., 1997.
57. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991;112:749-759.
58. Peterman EE, Taormina P, Harvey M, Young LH. Go 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion. J Cardiovasc Pharmacol 2004;43:645-656.
59. Phillipson A, Peterman EE, Taormina II P, et al. Protein kinase C zeta inhibition exerts cardioprotective effects in ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 2005;289:H898-H907.
60. Rahman A, Anwar KN, Malik AB. Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol 2000;279:C906-C914.
61. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-1023.
62. Rubanyi GM, Desiderio D, Luisi A, Johns A, Sybertz EJ. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels. J Pharmacol Exp Ther 1989;249:858-863.
63. Rubanyi GM, Vanhoutte P. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986;250:H815-H821.
64. Scalia R, Murohara T, Delyani JA, Nossuli TO, Lefer AM. Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfiision injury is mediated by inhibition of P-selection. J Leukoc Biol 1996;59:317-324.
65. Semb AG, Ytrehus K, Vaage J, Myklebust R and Mjos OD. Functional impairment in isolated rat hearts induced by activated leukocytes: Protective effect of oxygen free radical scavengers. J Mol Cell Cardiol 1989;21:877-887.
66. Shandelya S, Kuppusamy P, Wesfeldt M, Zweier JL. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury: Evidence for plasma-mediated leukocyte activation. Circulation 1993;87:536-546.
67. Stapf C, Mohr JP. Ischemic stroke therapy. Annu Rev Med 2002;53:453-475.
68. Strasser RH, Braun-Dullaeus R, Walendzik H, Marquetant R. alpha 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia. Circ Res 1992;70:1304-1312.
69. Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 2004;4:193-205.
70. Tasaki K, Hori M, Ozaki H, Karraki H, Wakabayashi I. Mechanism of human urotensin II- induced contraction in rat aorta. J Pharmacol Sci 2004;94:376-383.
71. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
72. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990;82:1402-1412.
73. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol 1990;259:H1660-H1666.
74. Tsushima H, Mori M, Fujiwara N, Moriyama A. Pharmacological characteristics if bombesin receptor mediating hypothermia in the central nervous system of rats. Brain Res 2003;969:88-94.
75. Ueno M, Moriyama Y, Toda R, et al. Effect of a neutrophil elastase inhibitor (ONO-5046 Na) on ischemia/reperfusion injury using the left-sided heterotopic canine heart transplantation model. J Heart Lung Transplant 2001;20:889-896.
76. Wilkinson SE, Parker PJ, Nixon JS. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 1993;294:335-337.
77. Woschnagg C, Garcia R, Rak S, Venge P. II-5 priming of the PMA-induced oxidative metabolism of human eosinophils allergic and normal subjects during a pollen season. Clin Exp Allergy 2001;31:555-564.
78. Yan SR, Novak MJ. Diverse effects of neutrophil integrin occupation on respiratory burst activation. Cell Immunol 1999;195:119-126.
79. Young LH, Ikeda Y, Lefer AM. Protein kinase inhibition exerts cardioprotective effects in myocardial ishemia/reperfusion via inhibition of super-oxide release. Meth Find Exp Clin Pharmacol 2001;23:107-114.
80. Young LH, Ikeda Y, Scalia R, Lefer AM. Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. J Pharmacol Exp Ther 2000;295:37-43.
81. Zhang J, Zhang M, Kazunori S, et al. D-cystathionine ketimine and L-cystathionine ketimine enhance superoxide generation by human neutrophils in a different manner. Arch Biochem Biophys 1999;363:55-59.
82. Zulueta JJ, Yu F-S, Hertig IA, Thannickal VJ, Hassoun PM. Release of hydrogen peroxide in response to hypoxia-reoxygenation: Role of an NADPH oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 1995;12:41-49.